Riskpilot← Back to searchSign inGet full accessANRO AS
ASActiveOrg 914987377Sagevegen 43, 6847 VassendenGeneral medical practice activities · NACE 8621Est. 20150 employees
Revenue 2024
NOK 4,3M
+6% vs 2023
EBITDA margin
92.7%
+9% vs 2023
Equity ratio
96.4%
Financial strength
Net profit 2024
NOK 3,6M
+16% vs 2023
| Revenue | NOK 4,3M | +6% |
| EBITDA | NOK 4M | +9% |
| Net profit | NOK 3,6M | +16% |
| Total assets | NOK 26,6M | +15% |
| Equity | NOK 25,7M | +16% |
| Employees | 0 | — |
Legal name
ANRO AS
Org number
914987377
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
18. februar 2015
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Allmenn legetjeneste, investering i verdipapirer, fast eiendom og kunst, samt deltagelse i og kjøp av andre selskaper og hva hertil står i forbindelse.
Address
Sagevegen 43, 6847 Vassenden
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 696 | 2 776 | 2 681 | 2 546 | 3 392 | 4 133 | 4 364 | 4 588 | 4 051 | 4 308 |
| Staff expenses | −10 | −12 | −19 | −15 | −12 | −21 | −28 | −25 | −29 | −9 |
| EBITDA | 2 510 | 2 595 | 2 482 | 2 366 | 3 123 | 3 761 | 4 089 | 4 179 | 3 674 | 3 993 |
| Depreciation & amort. | −0 | −0 | −2 | −13 | −18 | −136 | −194 | −201 | −196 | −69 |
| EBIT | 2 510 | 2 595 | 2 481 | 2 353 | 3 104 | 3 625 | 3 895 | 3 978 | 3 479 | 3 924 |
| Net financials | 1 | 2 | 2 | 52 | −176 | 74 | 113 | 210 | 483 | 593 |
| Profit before tax | 2 511 | 2 596 | 2 483 | 2 404 | 2 928 | 3 698 | 4 008 | 4 189 | 3 962 | 4 518 |
| Tax | 678 | 649 | 596 | 555 | 688 | 830 | 889 | 937 | 890 | 949 |
| Net profit | 1 833 | 1 947 | 1 887 | 1 850 | 2 240 | 2 868 | 3 119 | 3 252 | 3 072 | 3 569 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 586 | 4 511 | 6 301 | 8 127 | 10 476 | 13 533 | 16 678 | 20 171 | 23 058 | 26 625 |
| Equity | 1 863 | 3 810 | 5 697 | 7 547 | 9 787 | 12 655 | 15 773 | 19 025 | 22 097 | 25 666 |
| Long-term debt | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 724 | 701 | 603 | 579 | 689 | 879 | 905 | 1 145 | 961 | 959 |
| Total debt | 724 | 701 | 604 | 580 | 689 | 879 | 905 | 1 145 | 961 | 959 |
EBITDA margin
92.7%
This company
15.8%
Market median
+487% vs market
20152024
Equity ratio
96.4%
This company
38.2%
Market median
+152% vs market
20152024
Return on equity
13.9%
This company
18.4%
Market median
+24% vs market
20152024
Net profit margin
82.8%
This company
8.1%
Market median
+922% vs market
20152024
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20152024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AR Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
LB Deputy Member | Deputy Member | 2015 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ANRO AS 
ESTETIQUE ASBoard members of ANRO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Rosø | Chief Executive Officer | 0 companies |
| Lisbeth Borge | Deputy Member | 0 companies |